Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA
纳武利尤单抗联合伊匹木单抗和化疗作为转移性非小细胞肺癌患者一线治疗方案:CheckMate 9LA 研究的最终 6 年结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105123
Carbone, D P; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Felip, E; Cheng, Y; Juan-Vidal, O; Alexandru, A; Mizutani, H; Reinmuth, N; Lu, S; Reck, M; John, T; Scherpereel, A; De Marchi, P; Aoyama, T; Sathyanarayana, P; Grootendorst, D J; Hu, N; Ip, V; Hung, Y-H; Paz-Ares, L G